Estados financieros detallados de GRI Bio, Inc. (GRI): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $1.81, GRI presenta beneficios negativos (P/E no significativo) y un ROE del -134.03%. La capitalización bursátil es de $0M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | $100000 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $612 | $735 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$612 | -$735 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $3.5M | $1.9M | $264000 | $249000 | $242000 | $3.2M | $3.8M | $6.8M |
| Generales y Administrativos | $800076 | $1.3M | $1.2M | $813000 | $2.0M | $8.2M | $4.5M | $5.2M |
| Gastos Operativos | $4.3M | $3.2M | $1.5M | $1.1M | $2.2M | $11.4M | $8.2M | $12.0M |
| Beneficio Operativo | -$4.3M | -$3.2M | -$1.5M | -$1.1M | -$2.2M | -$11.4M | -$8.2M | -$12.0M |
| EBITDA | -$4.3M | -$3.3M | -$1.5M | -$1.1M | -$2.6M | -$11.0M | -$8.2M | -$12.0M |
| Gastos por Intereses | 0 | $197026 | $34000 | $547000 | $653000 | $2.1M | 0 | 0 |
| Beneficio Antes de Impuestos | -$4.3M | -$3.5M | -$2.5M | -$1.6M | -$3.2M | -$13.0M | -$8.2M | -$12.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$4.3M | -$3.5M | -$2.5M | -$1.6M | -$3.2M | -$13.0M | -$8.2M | -$12.0M |
| BPA | $-822780.00 | $-660968.00 | $-4693.64 | $-2827.16 | $-47135.48 | $-140450.24 | $0.33 | $-121.80 |
| BPA Diluido | $-822780.00 | $-660968.00 | $-4693.64 | $-2827.16 | $-47135.48 | $-140450.24 | $0.33 | $-121.80 |
| Acciones en Circulación (Diluidas) | $891 | $891 | $891 | $11602 | $1160 | $1578 | $4.9M | $98162 |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$3.4M | -$2.7M | -$2.0M | -$1.6M |
| EBITDA | -$3.4M | -$2.7M | -$2.0M | -$1.6M |
| Beneficio Neto | -$3.4M | -$2.7M | -$2.0M | -$1.6M |
| BPA | $-35.84 | $-5.34 | $-1.61 | $-0.91 |
| BPA Diluido | $-35.84 | $-5.34 | $-1.61 | $-0.91 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $612652 | $3.8M | $109000 | $90000 | $9000 | $1.8M | $5.0M | $8.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $637639 | $3.9M | $674000 | $96000 | $312000 | $2.9M | $5.6M | $8.6M |
| Inmovilizado Material | $1592 | $353902 | $281000 | $117000 | $71000 | $22000 | $124000 | $74000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $639231 | $4.3M | $955000 | $218000 | $383000 | $3.0M | $5.7M | $8.7M |
| Cuentas por Pagar | $286613 | $246329 | $1.2M | $57000 | $1.3M | $1.4M | $897000 | $1.8M |
| Deuda a Corto | 0 | $85665 | $152000 | $3.5M | $602000 | 0 | 0 | 0 |
| Pasivos Corrientes | $486292 | $807498 | $2.2M | $4.9M | $2.0M | $2.7M | $1.6M | $2.6M |
| Deuda a Largo | 0 | 0 | $14000 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $486292 | $1.1M | $2.4M | $4.9M | $2.0M | $2.7M | $1.7M | $2.7M |
| Reservas | -$4.3M | -$7.8M | -$12.6M | -$15.3M | -$18.5M | -$31.5M | -$39.7M | -$51.7M |
| Patrimonio Neto | $152939 | $3.2M | -$1.5M | -$4.7M | -$1.6M | $259000 | $4.0M | $6.0M |
| Deuda Total | 0 | $340021 | $336000 | $3.6M | $673000 | $14000 | $119000 | $71000 |
| Deuda Neta | -$612652 | -$3.5M | $227000 | $3.5M | $664000 | -$1.8M | -$4.9M | -$8.2M |
| Capital Circulante | $151347 | $3.1M | -$1.6M | -$4.8M | -$1.7M | $237000 | $4.0M | $5.9M |
Balance (Trimestral)
| Año | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q2 |
|---|
| Caja y Equivalentes | $4.1M | $8.2M | $11.0M | $10.9M |
| Activos Totales | $4.8M | $8.7M | $11.3M | $11.4M |
| Pasivos Totales | $2.8M | $2.7M | $794000 | $1.1M |
| Patrimonio Neto | $2.0M | $6.0M | $10.5M | $10.3M |
| Deuda Total | $84000 | $71000 | $58000 | $44000 |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$4.3M | -$3.5M | -$4.8M | -$9.3M | -$3.2M | -$13.0M | -$8.2M | -$12.0M |
| Amortizaciones | $612 | $735 | $75000 | $73000 | $3000 | $4000 | $4000 | $4000 |
| Compensación en Acciones | 0 | 0 | 0 | 0 | $25000 | $388000 | $148000 | $793000 |
| Cambio en Capital Circulante | $461305 | $159668 | $887000 | $220000 | $1.5M | $1.7M | -$448000 | $925000 |
| Flujo de Caja Operativo | -$2.4M | -$2.9M | -$3.7M | -$8.3M | -$1.1M | -$9.0M | -$8.6M | -$10.2M |
| Inversiones (CapEx) | -$2206 | -$5 | -$2000 | 0 | -$3000 | -$8000 | 0 | -$3000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | -$124000 | 0 | -$1000 | -$1000 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$2.4M | -$2.9M | -$3.7M | -$8.3M | -$1.1M | -$9.0M | -$8.6M | -$10.2M |
Flujo de Caja (Trimestral)
| Año | 2025-Q4 | 2026-Q1 | 2026-Q2 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$2.3M | -$3.0M | -$3.7M | -$1.4M |
| Inversiones (CapEx) | 0 | -$3000 | 0 | 0 |
| Flujo de Caja Libre | -$2.3M | -$3.0M | -$3.7M | -$1.4M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $465000 | $67000 | $31000 | $33000 |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | -100.0% | | | | |
| Crecimiento Beneficio Neto (anual) | | +19.7% | +26.9% | +38.4% | -106.4% | -305.3% | +37.0% | -45.7% |
| Crecimiento BPA (anual) | | +19.7% | +99.3% | +39.8% | -1567.2% | -198.0% | +100.0% | -37009.1% |
| Cambio en Acciones (anual) | | +0.0% | +0.0% | +1202.1% | -90.0% | +36.0% | +311426.1% | -98.0% |
| Crecimiento FCF (anual) | | -21.5% | -28.6% | -124.2% | +86.9% | -727.0% | +4.3% | -18.3% |
| Margen Bruto | | | 0.0% | | | | | |
| Margen Operativo | | | -1459.0% | | | | | |
| Margen EBITDA | | | -1456.0% | | | | | |
| Margen Neto | | | -2531.0% | | | | | |
| Margen FCF | | | -3708.0% | | | | | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-2663.54 | $-3236.52 | $-4161.62 | $-716.43 | $-937.93 | $-5702.15 | $-1.75 | $-103.80 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $891 | $891 | $891 | $11602 | $1160 | $1578 | $4.9M | $98162 |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -134.03% |
| Rentabilidad sobre capital invertido | -93.76% |
| Rentabilidad sobre activos | -84.88% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 10.30 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -12.00 | -14.94 | -2104.13 | -2748.66 | -8.00 | -0.12 | 1194.67 | -0.06 |
| P/VC | 57536.40 | 2738.05 | -6051.97 | -19085.07 | -269.01 | 101.59 | 478.66 | 0.11 |
| P/V | 0.00 | 0.00 | 87995.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | -1459.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | -2531.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |